Clinical Trial Update: Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating maintenance antiangiogenic therapy for ovarian cancer in remission was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Ovarian Carcinoma | Phase 2 | Status: TERMINATED